shanghai fosun pharmaceutical
Fosun & Guahao.com Partner For Pharma E-Commerce
The cooperation agreement between Fosun Pharmaceuticals and Guahao.com is expected to expand jxdyf.com’s pharmaceutical e-commerce platform.
Chinese Consortium Acquires Ambrx For Undisclosed Sum
The acquisition of Ambrx adds bio-conjugation capabilities to the WuXi PharmaTech-led consortium.
Reducing Malaria-Ebola Cross Infections
Guilin Pharma has increased its supply of anti-malarial drugs to Sub-Saharan Africa to reduce Ebola cross-infections.
Fosun Commits US$111 Million To Partnership With Public Hospital
The partnership between Fosun and Taizhou Muncipal Hospital will add approximately 2,000 new hospital beds to serve the residents of Taizhou.
Artemether, Guilin Pharma’s First WHO-certified API
Guilin Pharma has received its first WHO product quality certification for the anti-malaria drug Artemether, paving the way for other drugs in its portfolio.
Fosun Pharma Granted License For TB Alliance Drug
The public-private partnership between the Gates Foundation, TB alliance and Fosun Pharma aims to develop and commercialize a new TB drug in China.
Chindex To Merge With Fosun Pharma At Higher Share Price
Fosun Pharma and TPG increase their bid for Chindex from US$19.50 to US$24.00 per share.
Fosun Pharma And TPG To Acquire Chindex
Shanghai Fosun Pharmaceutical and TPG will acquire Chindex International for approximately $394 million.
Sirona Biochem Signs LOI With Wanbang Pharma
Sirona Biochem has signed a LOI with Wanbang Pharma to develop and commercialize its SGLT2 inhibitor in China.
